AMERICAN CANCER SOCIETY RECOGNIZES MERIT AND PROMISE OF LOCAL CANCER RESEARCH
FORT WORTH, Texasâ??The American Cancer Society (ACS) has recognized that North Texas is home to some of the countryâ??s leading cancer research and awarded one of its prestigious institutional research grants to the Institute for Cancer Research at the University of North Texas Health Science Center.
The award will be officially announced at a reception to be held at 3 p.m., Wednesday, May 23, in the UNT Health Science Center Atrium. For more information about the reception, call 817-735-2113.
According to ACS, the Instituteâ??s application for funding ranked second of the 26 new or competing renewals from many of the major cancer institutes in the United States. The UNT Health Science Center is the only North Texas institution to receive an ACS institutional research grant and one of only four in the state of Texas. The other three Texas recipients are Baylor College of Medicine, University of Texas Medical Branch at Galveston, and UT San Antonio Cancer Institute.
The institutional research grant provides $150,000 over a three-year period to fund junior faculty and their cancer-related projects, in such areas as basic science, translational and clinical research, prevention and control, early diagnosis and treatment, behavioral oncology research and educational programs. These start-up grants often later lead to additional funding at much higher levels by ACS, the federal government, and other sources.
“We are now recognized by our peers as an outstanding, new and developing Institute for Cancer Research,” said Ronald H. Goldfarb, Ph.D., institute director and principal investigator on the grant. “This award validates that the cancer research we are conducting in North Texas is of the highest quality.”
In addition to the UNT Health Science Center, other members of the cancer research grant consortium include the University of North Texas at Denton, Texas Christian University, Texas Wesleyan University, and the University of Texas at Arlington and its Automation and Robotics Research Institute. Junior researchers at these partner institutions are eligible to apply to the Institute for Cancer Research for funding from the ACS grant.
“The American Cancer Society is the largest private funder of cancer-related research in the world. The U. S. government is the only larger source of cancer research funding,” said Donna Rankin, executive director of the ACS Fort Worth metro unit. “We are extremely pleased to see that we are able to fund researchers who are working in our own backyard.”
The Institute for Cancer Research was established in January 1999 to study all aspects of cancer, with a focus on cancer that spreads in the human body. The Institute contributes to new approaches for cancer prevention, diagnosis and treatment.
ACS has funded over $2.3 billion in cancer research since 1946 when the program was first launched. Among these researchers are 30 Nobel Prize winners who received grant support from ACS early in their careers. Thirty-seven percent of every dollar given to ACS goes to fund this outstanding research program. In 1946, only 25 percent of cancer patients were alive five years after diagnosis. Today, almost 60 percent live longer than five years.
By Betsy Friauf At The University of North Texas Health Science Center at Fort Worth (HSC), student career readiness is enhanced in myriad ways. One of the latest is microcredentialing. Microcredentials are competency-based, specialized certifications attesting that a student has mastered ...Read more
Jul 15, 2020
By Sally Crocker As virus rates continue surging nationwide, a growing number of people are getting tested for COVID-19, and many have important questions on what to do while they await results. According to Dr. Diana Cervantes, faculty epidemiologist with the HSC School of Public Heal...Read more
Jul 15, 2020
By Diane Smith The University of North Texas Health Science Center at Fort Worth will be a new home and primary area of growth for CAGE Bio Inc., a privately held clinical-stage company, currently a resident company at Johnson & Johnson Innovation, JLABS@MBC BioLabs. The company is exp...Read more
Jul 14, 2020
During his tenure at HSC Fort Worth, Dr. Ralph Willard helped establish education, research and community service as the pillars that support the institution’s commitment to finding solutions for a healthier community, preventing disease and fostering a collaborative learning environment. T...Read more
Jul 13, 2020